Form 4 for RMD ResMed|
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-23 · accession 0001127602-22-026361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-23 | RMD | Douglas Robert Andrew | Pres, COO | F - Tax | $224.40 | -19.4K | 53.6K | -27% | -$4.36M | |
| 2022-11-23 | 2022-11-23 | RMD | Douglas Robert Andrew | Pres, COO | A - Grant | $0.00 | +32.8K | 73.0K | +82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-23 | F | D | 19,425 | $224.40 | 53,556 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-23 | A | A | 32,795 | $0.00 | 72,981 | D | — | — |